Literature DB >> 2310802

Increased production of thyroxine and inappropriately elevated serum thyrotropin in levels in endogenous depression.

C Kirkegaard1, A Kørner, J Faber.   

Abstract

The increased serum thyroxine (T4) levels in endogenous depression (ED) might be due to an increased production or a reduced degradation of T4. We therefore performed turnover studies of radiolabeled T4 and 3,5,3'-triiodothyronine (T3) in 6 patients with ED and 8 age-matched healthy controls. In ED, the median daily production of T4 was 130 nmol/day/70 kg, (range 100-186 nmol/day/70 kg) and elevated compared to control values which were 99 nmol/day/70 kg (range 85-142 nmol/day/70 kg) (p less than 0.05), whereas that of T3 was similar in the two groups. Serum thyrotropin (TSH) levels (0.90 mU/liter, 0.18-2.15 mU/liter) were elevated in ED compared to a group of 7 L-T4-treated hypothyroid subjects with similar production and serum levels of T4 and T3 (0.11 mU/liter, 0.07-1.10 mU/liter) (p less than 0.02). The data show that increased serum T4 levels in ED are secondary to an increased thyroidal production of T4, which is at least partly due to inappropriately high serum TSH levels.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2310802     DOI: 10.1016/0006-3223(90)90438-8

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  5 in total

1.  A quantitative assessment of depression and thyroid dysfunction secondary to interferon-alpha therapy in patients with hepatitis C.

Authors:  J M Loftis; J M Wall; E Linardatos; S Benvenga; P Hauser
Journal:  J Endocrinol Invest       Date:  2004 Jul-Aug       Impact factor: 4.256

2.  The Link between Thyroid Function and Depression.

Authors:  Mirella P Hage; Sami T Azar
Journal:  J Thyroid Res       Date:  2011-12-14

3.  Effect of Thyroxine Therapy on Depressive Symptoms Among Women With Subclinical Hypothyroidism.

Authors:  Maged M Costantine; Karen Smith; Elizabeth A Thom; Brian M Casey; Alan M Peaceman; Michael W Varner; Yoram Sorokin; Uma M Reddy; Ronald J Wapner; Kim Boggess; Alan T N Tita; Dwight J Rouse; Baha Sibai; Jay D Iams; Brian M Mercer; Jorge E Tolosa; Steve N Caritis; J Peter VanDorsten
Journal:  Obstet Gynecol       Date:  2020-04       Impact factor: 7.623

4.  Comparison of blood lipid profile/thyroid function markers between unipolar and bipolar depressed patients and in depressed patients with anhedonia or suicidal thoughts.

Authors:  Meilei Su; Enze Li; Chong Tang; Yongzhi Zhao; Ruqing Liu; Keming Gao
Journal:  Mol Med       Date:  2019-11-20       Impact factor: 6.354

Review 5.  Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder.

Authors:  Juan Joseph Young; Tim Silber; Davide Bruno; Isaac Robert Galatzer-Levy; Nunzio Pomara; Charles Raymond Marmar
Journal:  Front Psychiatry       Date:  2016-04-25       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.